Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes

BACKGROUND: Subtypes defined by hormonal receptor (HR) and HER2 status have not been well studied in inflammatory breast cancer (IBC). We characterized clinical parameters and long-term outcomes, and compared pathological complete response (pCR) rates by HR/HER2 subtype in a large IBC patient popula...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Masuda, H., Brewer, T. M., Liu, D. D., Iwamoto, T., Shen, Y., Hsu, L., Willey, J. S., Gonzalez-Angulo, A. M., Chavez-MacGregor, M., Fouad, T. M., Woodward, W. A., Reuben, J. M., Valero, V., Alvarez, R. H., Hortobagyi, G. N., Ueno, N. T.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3905780/
https://ncbi.nlm.nih.gov/pubmed/24351399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt525
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars